Delaware Senate Bill SJR7

Delaware 2025-2026 Regular Session

• Introduced: 5/9/25
• Introduced: 5/21/25
• Refer: 5/9/25
• Engrossed: 5/21/25
• Refer: 5/22/25
• Enrolled: 6/30/25
• Enrolled: 7/1/25
• Passed: 8/25/25

Caption

Directing The State Employee Benefits Committee And The Secretary Of Human Resources To Engage With Independent Consultants And Other Supply Chain Tactics For Cost Containment Of Prescription Drugs For State Employees And Retirees Insurance Programs.

Impact

The resolution aims to enhance the SEBC's ability to negotiate pharmaceutical pricing more effectively. By promoting transparency and data ownership regarding drug pricing, the SEBC can potentially avoid higher costs and abusive practices by PBMs. Additionally, the bill encourages the development of an independent Pharmacy and Therapeutics Committee, dedicated to reviewing drug formularies, which could result in wiser coverage decisions that prioritize cost-effectiveness and accountability for drug expenses within state insurance programs.

Summary

SJR7 is a joint resolution that directs the State Employee Benefits Committee (SEBC) and the Secretary of Human Resources to engage with independent consultants and implement other supply chain strategies to achieve cost containment for prescription drugs utilized by state employees and retirees. The resolution outlines significant issues such as the lack of transparency from pharmacy benefit managers (PBMs) in their pricing and rebate structures, which has been a growing concern for the General Assembly.

Sentiment

The general sentiment surrounding SJR7 appears to be supportive, particularly among those who underscore the need for cost-effective healthcare solutions for state employees and retirees. Lawmakers are acknowledging the financial strain that prescription drug costs place on the state's healthcare budget, and they appear committed to finding sustainable solutions. However, there are concerns that the proposed changes could disrupt existing relationships with PBMs or lead to unforeseen implementation challenges.

Contention

Notable points of contention include the balance between maintaining administrative flexibility and ensuring effective oversight over PBMs. While supporters advocate for greater control and transparency, there is apprehension among some stakeholders about the feasibility of the proposed strategies, particularly the establishment of an independent committee and the state's right to audit PBM contracts. The potential impacts of these regulatory changes will require careful consideration to ensure they benefit state employees without incurring excessive administrative burdens or complicating existing healthcare arrangements.